Bayview Legacy, LLC sold $3.1M of AIP (indirect holdings)
Bayview Legacy, LLC sold 100,000 indirectly-held shares of Arteris, Inc. (AIP) at an average of $30.51 ($28.79–$32.41, $3.05M total) across 5 trades over 2026-08-03 to 2026-08-04 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The only new fact is the reported sale size, price range, and that it was executed under a pre-arranged 10b5-1 plan. There is no accompanying corporate event, guidance, or regulatory development.
Market read
Traders may monitor for sentiment effects from owner selling, but the 10b5-1 structure makes it less actionable for fundamental repricing.
What to watch
Indirect holdings and multiple small lots can obscure intent; the filing does not provide new information about Arteris’ business, pipeline, or financial outlook.
Background
This is an SEC Form 4 insider transaction disclosure for Arteris, Inc., reported by Bayview Legacy, LLC as a 10% owner via indirect holdings.
Ticker impact
Arteris, Inc. (AIP) disclosed a 10b5-1 indirect open-market sale by Bayview Legacy totaling about $3.05M across 100,000 shares.
Likely limited, short-lived sentiment impact; no clear directional fundamental signal.
Form 4 shows a pre-arranged 10b5-1 plan and an open-market sale, which typically reduces interpretive weight versus discretionary selling.
Market effects
Minimal, as this is a single-company insider transaction with no operational or guidance change.
None.
None.
Counterpoint
Because the trades were executed under a pre-arranged 10b5-1 plan, the sale may reflect scheduled diversification rather than bearish expectations.
Key entities
- issuerArteris, Inc.
Subject of the Form 4 insider transaction disclosure (AIP).
- 10% ownerBayview Legacy, LLC
Reporter of the indirect open-market sale under a Rule 10b5-1 plan.
